Using data from community studies based at Duke Kannapolis, researchers found that COVID vaccination was not associated with new onset of APOL1-related kidney disease in African American adults who were at high risk for the condition.
The findings were published June 20 by Kidney International Reports. The authors concluded that validation of their result in larger cohorts would further support the renal safety of COVID vaccine in people with APOL1 high-risk genotype…
Read the full article here.
